A Patient-derived Organoid Platform for Uterine Carcinosarcoma that Emulates Disease Characteristics

Subhash, Santhilal, Bammert, Marie-Thérèse, Yueh, Brian, Ozler, Kadir A, Chu, Timothy, Kramer, Melissa, Belleau, Pascal, Deschênes, Astrid, Eskiocak, Onur, Chung, Charlie, Oku, Ali, Barbi, Mali, Alici, Aybuke, Gorman, Megan, Katcher, Arielle, Nizam, Aaron, Kredentser, Ariel, Bhana, Divya, Werner, Jonathan, Robine, Nicolas, Frimer, Marina, Goldberg, Gary L, Beyaz, Semir (April 2026) A Patient-derived Organoid Platform for Uterine Carcinosarcoma that Emulates Disease Characteristics. bioRxiv. ISSN 2692-8205 (Submitted)

[thumbnail of 10.64898.2026.04.21.720027.pdf] PDF
10.64898.2026.04.21.720027.pdf - Submitted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.
Download (41MB)

Abstract

Uterine carcinosarcoma (UCS) is a rare but highly lethal endometrial malignancy characterized by early dissemination, marked lineage plasticity, and limited therapeutic options. Although genomic studies have established UCS as a copy-number-high, carcinoma-like tumor with strong epithelial-mesenchymal transition (EMT) features, mechanistic and translational progress has been hindered by the lack of physiologically relevant patient-derived models, particularly models representing patients from African ancestry who are disproportionately affected by UCS. Here, we establish an ancestrally diverse cohort of UCS patient-derived organoids (PDOs) with matched normal endometrial PDOs that preserve the histological, genomic and transcriptional features of the tumors from which they were derived. Across the cohort, UCS PDOs retain somatic mutations, copy number alterations and recapitulate biphasic epithelial and mesenchymal cell states at single-cell resolution, and model dynamic transitions along an epithelial-to-mesenchymal continuum. Integrated bulk and single-cell analyses identify mesenchymal, proliferative, and metabolic transcriptional programs in UCS, with prominent enrichment of CREB-family motifs. Functionally, UCS PDOs reproduce heterogeneous responses to carboplatin and paclitaxel, reveal sensitivity to CREB inhibition, and suggest a potential cooperative vulnerability to combined FGFR and YAP pathway inhibition. Together, these data establish a genomically faithful and ancestrally inclusive UCS PDOs platform for studying tumor plasticity, lineage-state regulation, and therapy response in an understudied and clinically aggressive gynecologic cancer.

Item Type: Paper
Subjects: Investigative techniques and equipment
Investigative techniques and equipment > cell culture > cancer organoids
Investigative techniques and equipment > cell culture
CSHL Authors:
Communities: CSHL labs > Beyaz lab
CSHL labs > Gillis Lab
CSHL labs > Krasnitz lab
CSHL labs > McCombie lab
CSHL labs > Tuveson lab
CSHL Post Doctoral Fellows
School of Biological Sciences > Publications
SWORD Depositor: CSHL Elements
Depositing User: CSHL Elements
Date: 24 April 2026
Date Deposited: 01 Jul 2026 14:16
Last Modified: 01 Jul 2026 14:16
Related URLs:
URI: https://repository.cshl.edu/id/eprint/42256

Actions (login required)

Administrator's edit/view item Administrator's edit/view item